Sven Vanneste Selected Research

Tinnitus

1/2022	Different bimodal neuromodulation settings reduce tinnitus symptoms in a large randomized trial.
1/2022	Symptom dimensions to address heterogeneity in tinnitus.
1/2022	Predisposition to domain-wide maladaptive changes in predictive coding in auditory phantom perception.
1/2021	The BDNF Val66Met polymorphism regulates vulnerability to chronic stress and phantom perception.
1/2021	Vagus nerve stimulation for tinnitus: A review and perspective.
10/2020	Bimodal neuromodulation combining sound and tongue stimulation reduces tinnitus symptoms in a large randomized clinical study.
1/2020	Pre-treatment Ongoing Cortical Oscillatory Activity Predicts Improvement of Tinnitus After Partial Peripheral Reafferentation With Hearing Aids.
9/2019	Noninvasive Bimodal Neuromodulation for the Treatment of Tinnitus: Protocol for a Second Large-Scale Double-Blind Randomized Clinical Trial to Optimize Stimulation Parameters.
1/2019	Changes in the Resting-State Cortical Oscillatory Activity 6 Months After Modified Tinnitus Retraining Therapy.
2/2018	Influencing connectivity and cross-frequency coupling by real-time source localized neurofeedback of the posterior cingulate cortex reduces tinnitus related distress.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sven Vanneste Research Topics

Disease

57	Tinnitus 01/2022 - 04/2010
21	Pain (Aches) 11/2021 - 05/2010
7	Neuralgia (Stump Neuralgia) 04/2020 - 05/2010
6	Failed Back Surgery Syndrome 01/2017 - 07/2011
5	Deafness (Deaf Mutism) 01/2018 - 05/2013
5	Fibromyalgia (Fibrositis) 01/2018 - 10/2015
4	Traumatic Brain Injuries (Traumatic Brain Injury) 03/2022 - 01/2020
4	Chronic Pain 11/2021 - 03/2015
4	Paresthesia (Dysesthesia) 01/2020 - 05/2010
3	Intractable Pain 04/2021 - 01/2016
3	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 01/2017
2	Cognitive Dysfunction 11/2021 - 01/2019
2	Schizophrenia (Dementia Praecox) 01/2021 - 01/2017
2	Alcoholism (Alcohol Abuse) 01/2020 - 01/2017
2	Food Addiction 01/2018 - 01/2018
2	Stroke (Strokes) 01/2017 - 01/2014
2	Hearing Loss (Hearing Impairment) 01/2017 - 02/2013
2	Epilepsy (Aura) 01/2017 - 01/2017
2	Back Pain (Backache) 01/2015 - 11/2013
1	Paranoid Disorders (Paranoia) 09/2021
1	Mood Disorders (Mood Disorder) 01/2021
1	Neuroinflammatory Diseases 01/2021
1	Nervous System Diseases (Neurological Disorders) 11/2020
1	Memory Disorders (Memory Loss) 01/2019
1	Mental Disorders (Mental Disorder) 01/2018
1	Obesity 01/2018
1	Sleepiness 01/2018
1	misophonia 01/2018
1	Telomeric 22q13 Monosomy Syndrome 01/2018
1	Ischemic Stroke 12/2017
1	Hyperacusis (Phonophobia) 10/2017
1	Treatment-Resistant Depressive Disorder 04/2017
1	Infections 04/2017
1	Seizures (Absence Seizure) 04/2017
1	Movement Disorders (Movement Disorder) 01/2017
1	Fatigue 01/2017
1	Multiple Sclerosis 01/2017
1	Parkinson Disease (Parkinson's Disease) 01/2017
1	Consciousness Disorders 01/2017
1	Aphasia (Dysphasia) 01/2017
1	Headache (Headaches) 01/2017
1	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 04/2016
1	Trigeminal Neuralgia (Tic Douloureux) 01/2016
1	Hemifacial Spasm 01/2016
1	Chronic Disease (Chronic Diseases) 01/2015
1	Diabetic Neuropathies (Diabetic Neuropathy) 02/2014
1	Wernicke Aphasia (Receptive Aphasia) 01/2014
1	Causalgia (Syndrome, Causalgia) 12/2013
1	Neoplasms (Cancer) 12/2013
1	Hyperalgesia 12/2013
1	Depressive Disorder (Melancholia) 10/2012
1	Neglected Diseases 11/2011

Drug/Important Bio-Agent (IBA)

11	salicylhydroxamic acid (SHAM)IBA 09/2021 - 10/2011
9	Therapeutic UsesIBA 01/2022 - 01/2012
6	Pharmaceutical PreparationsIBA 01/2018 - 01/2012
3	Silver Sulfadiazine (SSD)FDA LinkGeneric 10/2017 - 05/2013
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2016
2	Indicators and Reagents (Reagents)IBA 01/2020 - 10/2017
2	TESIBA 01/2017 - 01/2013
1	Biological ProductsIBA 01/2022
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2021
1	ApolipoproteinsIBA 01/2021
1	Estrogens (Estrogen)FDA Link 01/2021
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2021
1	methionylmethionine (Met-Met)IBA 01/2018
1	valylvaline (Val-Val)IBA 01/2018
1	Dihydrotachysterol (AT 10)IBA 04/2016
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2016
1	Amylases FDA Link 01/2016
1	NeopterinIBA 01/2016
1	ProdigyIBA 03/2015
1	Pain-FreeIBA 11/2013
1	Naltrexone (ReVia)FDA LinkGeneric 01/2013
1	Analgesics (Analgesic Drugs)IBA 05/2012
1	cyclobenzaprine FDA LinkGeneric 05/2012
1	Antidepressive Agents (Antidepressants)IBA 05/2012
1	Nonprescription Drugs (Patent Medicines)IBA 11/2011

Therapy/Procedure

30	Transcranial Direct Current Stimulation 03/2022 - 05/2010
17	Spinal Cord Stimulation 11/2021 - 05/2010
17	Electrodes (Electrode) 01/2018 - 05/2010
15	Transcranial Magnetic Stimulation 01/2018 - 04/2011
9	Implanted Electrodes 01/2020 - 06/2010
8	Therapeutics 11/2021 - 04/2015
5	Vagus Nerve Stimulation 01/2021 - 02/2014
5	Drug Therapy (Chemotherapy) 01/2018 - 01/2012
4	Neurofeedback 02/2018 - 07/2012
4	Transcutaneous Electric Nerve Stimulation (TENS) 11/2013 - 07/2010
3	Cochlear Implants (Cochlear Implant) 01/2018 - 12/2014
3	Deep Brain Stimulation 04/2017 - 07/2012
2	Psychosurgery (Lobotomy) 11/2021 - 04/2016
2	Aftercare (After-Treatment) 10/2020 - 04/2015
2	Cognitive Training 01/2019 - 01/2018
2	Cochlear Implantation 01/2017 - 05/2013
2	Microvascular Decompression Surgery 01/2016 - 04/2010
1	Hearing Aids (Hearing Aid) 01/2020
1	Self-Help Devices (Assistive Technology) 01/2017
1	Precision Medicine 01/2016
1	Complementary Therapies (Alternative Medicine) 01/2015
1	Anesthesia 12/2013
1	Music Therapy 02/2013